Trademark: 90273164
Word

Status
Dead
Status Code
606
Status Date
Monday, April 17, 2023
Serial Number
90273164
Mark Type
2000
Filing Date
Friday, October 23, 2020
Published for Opposition
Tuesday, January 18, 2022
Abandoned Date
Monday, April 17, 2023

Trademark Owner History
Platelet BioGenesis Inc. - Owner At Publication

Classifications
5 Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use
The mark consists of a Pegasus design.

Trademark Events
Apr 17, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 17, 2023
Abandonment - No Use Statement Filed
Sep 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2022
Sou Extension 1 Granted
Sep 13, 2022
Sou Extension 1 Filed
Sep 13, 2022
Teas Extension Received
May 24, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 11, 2022
Case Assigned To Intent To Use Paralegal
Apr 6, 2022
Teas Post Publication Amendment Received
Mar 15, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 18, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2022
Published For Opposition
Dec 29, 2021
Notification Of Notice Of Publication E-Mailed
Dec 15, 2021
Approved For Pub - Principal Register
Oct 9, 2021
Teas/Email Correspondence Entered
Oct 8, 2021
Correspondence Received In Law Office
Oct 8, 2021
Teas Response To Office Action Received
Apr 8, 2021
Notification Of Non-Final Action E-Mailed
Apr 8, 2021
Non-Final Action E-Mailed
Apr 8, 2021
Non-Final Action Written
Mar 24, 2021
Assigned To Examiner
Dec 12, 2020
Notice Of Design Search Code E-Mailed
Dec 11, 2020
New Application Office Supplied Data Entered
Oct 27, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24